N,N'-Diacetyl-L-cystine

Research use only, not for human use.

N,N'-Diacetyl-L-cystine is the disulphide dimer of N-acetylcysteine with immunomodulating properties.

N,N'-Diacetyl-L-cystine is the disulphide dimer of N-acetylcysteine with immunomodulating properties. N,N'-diacetyl-L-cystine also has antiatherosclerotic effects in Watanabe-heritable hyperlipidemic rabbit (WHHL) rabbits. N,N'-diacetyl-L-cystine is also an effective and orally active modulator of contact sensitivity/delayed-type hypersensitivity reactions in rodents.(In Vivo):N,N'-Diacetyl-L-cystine (DiNAC; 0-973.11 μg/kg; p.o.; daily; for 12 weeks; WHHL rabbits) treatment decreases by 50% thoracic aorta atherosclerosis. However, it has no affecting plasma lipid levels.

——

N,N'-Diacetyl-L-cystine (DiNAC; 0-973.11 μg/kg; oral administration; daily; for 12 weeks; WHHL rabbits) treatment reduces by 50% thoracic aorta atherosclerosis, without affecting plasma lipid levels. Animal Model:Male heritable hyperlipidemic rabbit (WHHL) rabbits (10-22 weeks) Dosage:0 μg/kg, 9.73 μg/kg, or 973.11 μg/kg Administration:Oral administration; daily; for 12 weeks Result:Reduced by 50% thoracic aorta atherosclerosis, without affecting plasma lipid levels.

DiNAC

Others

Other Targets

CDK4/CyclinD1| CDK6/CyclinD3

——

——

5545-17-5

324.37

C10H16N2O6S2

>98% (HPLC)

In Vitro:?DMSO : 125 mg/mL (385.36 mM)

O=C(O)[C@H](CSSC[C@@H](C(O)=O)NC(C)=O)NC(C)=O

——

(-20℃)

With Ice Pack

≥ 2 years